Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development a... Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements). 詳細を表示
LOS ANGELES, Aug. 08, 2024 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.74 | 35.5102040816 | 4.9 | 6.9 | 4.7 | 71083 | 5.80306662 | CS |
4 | -1.14 | -14.6529562982 | 7.78 | 8.2 | 3.8181 | 264434 | 6.03950892 | CS |
12 | -3.12 | -31.9672131148 | 9.76 | 9.76 | 3.8181 | 566681 | 7.01460232 | CS |
26 | -6.16 | -48.125 | 12.8 | 13.2 | 3.8181 | 674952 | 7.7221615 | CS |
52 | -147.16 | -95.6827048114 | 153.8 | 162 | 3.8181 | 551017 | 33.10242623 | CS |
156 | -190.76 | -96.6362715299 | 197.4 | 356.4 | 3.8181 | 502406 | 54.63759706 | CS |
260 | 0 | 0 | 0 | 6.74 | 0 | 0 | 0 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約